Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study

References

• Holowiecki J. Indications for hematopoietic stem cell transplantation. Pol Arch Med Wewn. 2008; 118(11): 658–663. Doi: https://doi.org/10.20452/pamw.516.
   PubMedGoogle Scholar
• Balassa K, Danby R, Rocha V. Haematopoietic stem cell transplants: principles and indications. Br J Hosp Med (Lond). 2019; 80(1): 33–39. Doi: https://doi.org/10.12968/hmed.2019.80.1.33.
   PubMed Web of Science ®Google Scholar
• Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992; 67(2): 117–122. Doi: https://doi.org/10.1016/s0025-6196(12)61310-x.
   PubMed Web of Science ®Google Scholar
• Galindo-Becerra S, Labastida-Mercado N, Rosales-Padrón J, García-Chavez J, Soto-Vega E, Rivadeneyra-Espinoza L, et al. Outcome of recipients of hematopoietic stem cell transplants who require intensive care unit support: a single institution experience. Acta Haematol. 2015; 134(2): 119–124. Doi: https://doi.org/10.1159/000381301.
   PubMed Web of Science ®Google Scholar
• Denardo SJ, Oye RK, Bellamy PE. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med. 1989; 17(1): 4–6. Doi: https://doi.org/10.1097/00003246-198901000-00002.
   PubMed Web of Science ®Google Scholar
• Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE, et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant. 1998; 21(7): 697–704. Doi: https://doi.org/10.1038/sj.bmt.1701158.
   PubMed Web of Science ®Google Scholar
• Matulis M, High KP. Immune reconstitution after hematopoietic stem-cell transplantation and its influence on respiratory infections. Semin Respir Infect. 2002; 17(2): 130–139. Doi: https://doi.org/10.1053/srin.2002.33441.
   PubMedGoogle Scholar
• Boyacı N, Aygencel G, Turkoglu M, Yegin ZA, Acar K, Sucak GT. The intensive care management process in patients with hematopoetic stem cell transplantation and factors affecting their prognosis. Hematology. 2014; 19: 338–345. Doi: https://doi.org/10.1179/1607845413Y.0000000130.
   PubMed Web of Science ®Google Scholar
• Barnes RA, Stallard N. Severe infections after bone marrow transplantations. Curr Opin Crit Care. 2001; 7(5): 362–366. Doi: https://doi.org/10.1097/00075198-200110000-00008.
   PubMedGoogle Scholar
• Ninin E, Milpied N, Moreau P, André-Richet B, Morineau N, Mahéet B, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis. 2001; 33(1): 41–47. Doi: https://doi.org/10.1086/320871.
   PubMed Web of Science ®Google Scholar
• Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Infect Dis Clin North Am. 2010; 24(2): 257–272. Doi: https://doi.org/10.1016/j.idc.2010.01.010.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315(8): 801–810. Doi: https://doi.org/10.1001/jama.2016.0287.
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults With hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis. 2016; 63(5): e61–111. Doi: https://doi.org/10.1093/cid/ciw353.
   PubMed Web of Science ®Google Scholar
• O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. .Clin Infect Dis. 2011; 52(9): e162-93. doi: https://doi.org/10.1093/cid/cir257.
   Google Scholar
• Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA, Healthcare Infection Control Practices Advisory Committee . Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010; 31(4): 319-26. doi: https://doi.org/10.1086/651091.
   Google Scholar
• Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, et al . Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48 (5): 503–535. Doi: https://doi.org/10.1086/596757.
   Web of Science ®Google Scholar
• Maertens J, Marchetti O, Herbrecht R, Cornely OA, Flückiger U, Frêre P, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 update. Bone Marrow Transplant. 2011; 46: 709–718. Doi: https://doi.org/10.1038/bmt.2010.175.
   PubMed Web of Science ®Google Scholar
• Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002; 34(8): 1094–1097. Doi: https://doi.org/10.1086/339329.
   PubMed Web of Science ®Google Scholar
• ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012; 307(23): 2526–2533. Doi: https://doi.org/10.1001/jama.2012.5669.
   PubMed Web of Science ®Google Scholar
• Venkataraman R, Kellum JA. Defining acute renal failure: the RIFLE criteria. J Intensive Care Med. 2007; 22(4): 187–193. Doi: https://doi.org/10.1177/0885066607299510
   PubMedGoogle Scholar
• Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for blood and Marrow transplant activity survey report. Bone Marrow Transplant. 2017; 52(6): 811–881. Doi: https://doi.org/10.1038/bmt.2017.34.
   PubMed Web of Science ®Google Scholar
• Afessa B, Azoulay E. Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin. 2010; 26 (1): 133–150. Doi: https://doi.org/10.1016/j.ccc.2009.09.001
   Web of Science ®Google Scholar
• Agarwal S, O’Donoghue S, Gowardman J, Kennedy G, Bandeshe H, Boots R . Intensive care unit experience of haemopoietic stem cell transplant patients. Intern Med J. 2012; 42: 748–754. Doi: https://doi.org/10.1111/j.1445-5994.2011.02533.x.
   PubMed Web of Science ®Google Scholar
• Saillard C, Blaise D, Mokart D. Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant. 2016; 51: 1050–1061. Doi: https://doi.org/10.1038/bmt.2016.72.
   PubMed Web of Science ®Google Scholar
• Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA. Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care. 2008; 12(3): R77. Doi: https://doi.org/10.1186/cc6923
   PubMed Web of Science ®Google Scholar
• Paz HL, Crilley P, Weinar M, Brodsky I. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest. 1993; 104(2): 527–531. Doi: https://doi.org/10.1378/chest.104.2.527
   PubMed Web of Science ®Google Scholar
• Soubani AO, Kseibi E, Bander JJ, Klein JL, Khanchandani G, Ahmed HP, et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest. 2004; 126(5): 1604–1611. Doi: https://doi.org/10.1378/chest.126.5.1604
   PubMed Web of Science ®Google Scholar
• Lueck C, Stadler M, Koenecke C, Hoeper MM , Dammann E, Schneider A, et al. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med. 2018; 44(9): 1483–1492. Doi: https://doi.org/10.1007/s00134-018-5347-x.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Pene F, Darmon M, Lengliné E, Benoit D, Soares M, et al. Managing critically Ill Hematology patients: time to think differently. Blood Rev. 2015; 29: 359–367. Doi: https://doi.org/10.1016/j.blre.2015.04.002
   PubMed Web of Science ®Google Scholar
• Michel CS, Teschner D, Schmidtmann I, Theobald M, Hauptrock B, Wagner-Drouet EM, et al. Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization. Sci Rep. 2019; 9(1): 19911. Doi: https://doi.org/10.1038/s41598-019-56322-0.
   PubMedGoogle Scholar
• Lindgaard SC, Nielsen J, Lindmark A, Sengeløv H. Prognosis of allogeneic Haematopoietic stem cell recipients admitted to the intensive care unit: a retrospective, single-centre study. Acta Haematol. 2016; 135(2): 72–78. Doi: https://doi.org/10.1159/000440937.
   PubMed Web of Science ®Google Scholar
• Trinkaus MA, Lapinsky SE, Crump M, Keating A, Reece DE, Chen C,et al. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant. 2009; 43: 411–415. Doi: https://doi.org/10.1038/bmt.2008.336.
   PubMed Web of Science ®Google Scholar
• Benz R, Schanz U, Maggiorini M, Seebach JD, Stussi G, et al. Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014; 49: 62–65. Doi: https://doi.org/10.1038/bmt.2013.141.
   PubMed Web of Science ®Google Scholar
• Mokart D, Granata A, Crocchiolo R, Sannini A, Chow-Chine L, Brun JP, et al. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care. 2015; 30: 1107–1113. Doi: https://doi.org/10.1016/j.jcrc.2015.06.020.
   PubMed Web of Science ®Google Scholar
• Neumann F, Lobitz O, Fenk R, Bruns I, Köstering M, Steiner S, et al. The sepsis-related organ failure assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol. 2008; 87: 299–304. Doi: https://doi.org/10.1007/s00277-008-0440-9.
   PubMed Web of Science ®Google Scholar
• Afessa B, Tefferi A, Dunn WF, Litzow MR, Peters SG. Intensive care unit support and acute physiology and chronic health evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med. 2003; 31: 1715–1721. Doi: https://doi.org/10.1097/01.CCM.0000065761.51367.2D.
   PubMed Web of Science ®Google Scholar
• Gilli K, Remberger M, Hjelmqvist H, Ringden O, Mattsson J. Sequential organ failure assessment predicts the outcome of SCT recipients admitted to intensive care unit. Bone Marrow Transplant. 2010; 45: 682–688. Doi: https://doi.org/10.1038/bmt.2009.220.
   PubMed Web of Science ®Google Scholar
• Groeger JS, Lemeshow S, Price K, Nierman DM, White P Jr, Klar J, et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol. 1998; 16: 761–770. Doi: https://doi.org/10.1200/JCO.1998.16.2.761.
   PubMed Web of Science ®Google Scholar
• Bayraktar UD, Milton DR, Shpall EJ, Rondon G, Price KJ, Champlin RE, et al. Prognostic index for critically Ill allogeneic transplantation patients. Biol Blood Marrow Transplant. 2017; 23: 991–996. Doi: https://doi.org/10.1016/j.bbmt.2017.03.003.
   PubMed Web of Science ®Google Scholar
• Kobayashi R, Iguchi A, Nakajima M, Sato T, Yoshida M, Kaneda M, et al. Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation. Bone Marrow Transplant. 2004; 34(11): 975–979. Doi: https://doi.org/10.1038/sj.bmt.1704688.
   PubMed Web of Science ®Google Scholar
• Yuda S, Mori T, Kato J, Koda Y, Kohashi S, Kikuchi T, et al. Sodium-losing nephropathy caused by tacrolimus after allogeneic hematopoietic stem cell transplantation. Rinsho Ketsueki. 2013; 54(12): 2187–2191. Doi: https://doi.org/10.11406/rinketsu.54.2187.
   PubMedGoogle Scholar
• Sahin U, Toprak SK, Atilla PA, Atilla E, Demirer T. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2016; 22: 505–514. Doi: https://doi.org/10.1016/j.jiac.2016.05.006.
   PubMed Web of Science ®Google Scholar
• Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, et al. Infections in hematopoietic cell transplant recipients: results from the organ transplant infection project, a multicenter, prospective, cohort study. Open Forum Infect Dis. 2017;4(2):ofx050. Doi: https://doi.org/10.1093/ofid/ofx050.
   PubMed Web of Science ®Google Scholar
• César-Arce A, Volkow-Fernández P, Valero-Saldaña LM , Acosta-Maldonado B , Vilar-Compte D, Cornejo-Juárez P Infectious complications and multidrug-resistant bacteria in patients with hematopoietic stem cell transplantation in the first 12 months after transplant. Transplant Proc. 2017; 49(6): 1444–1448. Doi: https://doi.org/10.1016/j.transproceed.2017.03.081.
   PubMed Web of Science ®Google Scholar
• Altuntaş F, Yıldız O, Eser B, Alp E, Sarı İ, Çetin M, et al. Microbiologically documented infections following peripheral blood stem cell transplantation: single center experience. Turk J Haematol. 2005; 22(3): 133–145. PMID: 27264835.
   PubMedGoogle Scholar
• Oliveira AL, de Souza M, Carvalho-Dias VMH, Ruiz MA, Silla L, Tanaka PY, et al. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2007; 39: 775–781. Doi: https://doi.org/10.1038/sj.bmt.1705677.
   PubMed Web of Science ®Google Scholar
• Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, et al.; Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect. 2010; 138(7): 1044–1051. Doi: https://doi.org/10.1017/S0950268809991208.
   PubMed Web of Science ®Google Scholar
• Ali N, Adil SN, Shaikh MU. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country. Transpl Infect Dis. 2014; 16(1): 98–105. Doi: https://doi.org/10.1111/tid.12176.
   PubMed Web of Science ®Google Scholar
• Fuji S, Einsele H, Kapp M. Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options. Curr Opin Infect Dis. 2017; 30(4): 372–376. Doi: https://doi.org/10.1097/QCO.0000000000000375.
   PubMed Web of Science ®Google Scholar
• Bays DJ, Thompson GR 3rd . Fungal infections of the stem cell transplant recipient and hematologic malignancy patients. Infect Dis Clin N Am. 2019; 33: 545–566. Doi: https://doi.org/10.1016/j.idc.2019.02.006.
   PubMed Web of Science ®Google Scholar
• Omer AK, Ziakas PD, Anagnostou T, Coughlin E, Kourkoumpetis T, McAfee SL, et al. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. Biol Blood Marrow Transplant. 2013; 19(8): 1190–1196. Doi: https://doi.org/10.1016/j.bbmt.2013.05.018.
   PubMed Web of Science ®Google Scholar